Skip to main content

Merck third-quarter results beat estimates, boosted by cancer drug and vaccine growth

Drugmaker raises full-year sales outlook but cuts earnings guidance as it digests recent deals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.